BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35433999)

  • 1. Non-mass enhancement breast lesions: MRI findings and associations with malignancy.
    Liu G; Li Y; Chen SL; Chen Q
    Ann Transl Med; 2022 Mar; 10(6):357. PubMed ID: 35433999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of combined clinical-radiomics model based on contrast-enhanced MRI in predicting the malignancy of breast non-mass enhancements without an additional diffusion-weighted imaging sequence.
    Li Y; Yang Z; Lv W; Qin Y; Tang C; Yan X; Yin T; Ai T; Xia L
    Quant Imaging Med Surg; 2023 Sep; 13(9):5974-5985. PubMed ID: 37711822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI.
    Avendano D; Marino MA; Leithner D; Thakur S; Bernard-Davila B; Martinez DF; Helbich TH; Morris EA; Jochelson MS; Baltzer PAT; Clauser P; Kapetas P; Pinker K
    Breast Cancer Res; 2019 Dec; 21(1):136. PubMed ID: 31801635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of dynamic contrast enhancement and diffusion-weighted MRI for differentiation of benign from malignant non-mass enhancement breast lesions.
    Zhang J; Li L; Zhang L; Zhe X; Tang M; Lei X; Zhang X
    Front Oncol; 2024; 14():1332783. PubMed ID: 38544833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Features in Probably Benign and Malignant Nonmass Enhancement in Breast MRI.
    Ahmadinejad N; Azizinik F; Khosravi P; Torabi A; Mohajeri A; Arian A
    Int J Breast Cancer; 2024; 2024():6661849. PubMed ID: 38523651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Combined Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MRI for Differentiating Malignant From Benign Breast Lesions Presenting Washout Curve.
    Tezcan S; Ozturk FU; Uslu N; Akcay EY
    Can Assoc Radiol J; 2021 Aug; 72(3):460-469. PubMed ID: 32157892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrasts Between Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MR in Diagnosing Malignancies of Breast Nonmass Enhancement Lesions Based on Morphologic Assessment.
    Li Y; Chen J; Yang Z; Fan C; Qin Y; Tang C; Yin T; Ai T; Xia L
    J Magn Reson Imaging; 2023 Sep; 58(3):963-974. PubMed ID: 36738118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
    Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
    Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of Additional Non-Mass Enhancement in Patients with Breast Cancer on Preoperative 3T Dynamic Contrast Enhanced MRI of the Breast.
    Cho YH; Cho KR; Park EK; Seo BK; Woo OH; Cho SB; Bae JW
    Iran J Radiol; 2016 Jan; 13(1):e30909. PubMed ID: 27127579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging features of idiopathic granulomatous mastitis: is there any contribution of diffusion-weighted imaging in the differential diagnosis?
    Yilmaz R; Demir AA; Kaplan A; Sahin D; Ozkurt E; Dursun M; Acunas G
    Radiol Med; 2016 Nov; 121(11):857-866. PubMed ID: 27406630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between dynamic contrast-enhanced MRI characteristics and apparent diffusion coefficient with Ki-67-positive expression in non-mass enhancement of breast cancer.
    Nie T; Feng M; Yang K; Guo X; Yuan Z; Zhang Z; Yan G
    Sci Rep; 2023 Dec; 13(1):21451. PubMed ID: 38052920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MRI characteristics of non-mass enhancement lesions of the breast: associations with malignancy.
    Aydin H
    Br J Radiol; 2019 Apr; 92(1096):20180464. PubMed ID: 30673299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.
    Imamura T; Isomoto I; Sueyoshi E; Yano H; Uga T; Abe K; Hayashi T; Honda S; Yamaguchi T; Uetani M
    Magn Reson Med Sci; 2010; 9(4):217-25. PubMed ID: 21187691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
    Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
    J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Dynamic Contrast-Enhanced MRI and Non-Mono-Exponential Model-Based Diffusion-Weighted Imaging for the Prediction of Prognostic Biomarkers and Molecular Subtypes of Breast Cancer Based on Radiomics.
    Zhang L; Zhou XX; Liu L; Liu AY; Zhao WJ; Zhang HX; Zhu YM; Kuai ZX
    J Magn Reson Imaging; 2023 Nov; 58(5):1590-1602. PubMed ID: 36661350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential diagnosis of mammographically and clinically occult breast lesions on diffusion-weighted MRI.
    Partridge SC; Demartini WB; Kurland BF; Eby PR; White SW; Lehman CD
    J Magn Reson Imaging; 2010 Mar; 31(3):562-70. PubMed ID: 20187198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast lesion characterization using whole-lesion histogram analysis with stretched-exponential diffusion model.
    Liu C; Wang K; Li X; Zhang J; Ding J; Spuhler K; Duong T; Liang C; Huang C
    J Magn Reson Imaging; 2018 Jun; 47(6):1701-1710. PubMed ID: 29165847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.
    Fan WX; Chen XF; Cheng FY; Cheng YB; Xu T; Zhu WB; Zhu XL; Li GJ; Li S
    Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Values of Minimal Apparent Diffusion Coefficient,Difference between Ratios of Apparent Diffusion Coefficients,and Dynamic Contrast-enhanced Magnetic Resonance Imaging Features in Diagnosing Breast Ductal Carcinoma In Situ with Microinvasion].
    Wu P; Cui L; Guo BH; Wang YC; Cui JS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Dec; 41(6):737-745. PubMed ID: 31907122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.